The Current Role of Botox in a Pediatric Neurogenic Bladder Condition

被引:3
|
作者
Kroll, Pawel [1 ]
机构
[1] Poznan Univ Med Sci, Pediat Surg & Urol Clin, Neurourol Unit, Ul Pamiatkowa 2-42, PL-61512 Poznan, Poland
关键词
Botulinum toxin; Neurogenic bladder; Child; BOTULINUM-TOXIN-A; IDIOPATHIC DETRUSOR OVERACTIVITY; SINGLE-CENTER EXPERIENCE; NEUROPATHIC BLADDER; INTRADETRUSOR ONABOTULINUMTOXINA; INTRAVESICAL INJECTION; BOWEL DYSFUNCTION; NERVE-FIBERS; SPINA-BIFIDA; CHILDREN;
D O I
10.1007/s11884-019-00516-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review The neurogenic bladder is a medical term that describes a variety of bladder and sphincter dysfunctions. There are two major dangerous functional problems in a child with neurogenic bladder: high intravesical pressure in the storage phase and high pressure during urination. Two basic goals for urologic treatment in those children are protection of urinary tract from complications and improvement of continence in older children. This review focuses on the current role of botulinum toxin treatment in children with neurogenic bladder. Recent Findings At the beginning, treatment in this group of children is conservative. Oral anticholinergic therapy is aimed at decreasing bladder pressures during the storage phase. Clean intermittent catheterization enables bladder emptying if voiding is insufficient. Nevertheless, in a number of children such an approach fails, in some patients, troublesome side effects occur. In cases when standard therapy provides no improvement or if complications develop on the proper conservative treatment, surgical procedures are suggested. Operations are aimed at the surgical enlargement of bladder capacity. There are some reports on the efficacy of cystoscopic detrusor botulinum toxin injections in the treatment of neurogenic bladder in children. Summary Cystoscopic administration of botulinum toxin represents an alternative method of treatment to surgery for children with neurogenic bladder and could be considered an alternative to oral anticholinergic therapy.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 50 条
  • [1] The Current Role of Botox in a Pediatric Neurogenic Bladder Condition
    Paweł Kroll
    Current Bladder Dysfunction Reports, 2019, 14 : 115 - 123
  • [2] Botox for the Neurogenic Bladder
    Harris C.J.
    Dmochowski R.
    Reynolds W.S.
    Current Bladder Dysfunction Reports, 2013, 8 (4) : 312 - 318
  • [3] The role of urethral dilation in managing pediatric neurogenic bladder dysfunction
    Wan J.
    Current Urology Reports, 2009, 10 (2) : 153 - 158
  • [4] The role of urethral dilation in managing pediatric neurogenic bladder dysfunction
    Wan J.
    Current Bladder Dysfunction Reports, 2008, 3 (3) : 127 - 132
  • [5] Pharmacotherapy for Pediatric Neurogenic Bladder
    Kroll, Pawel
    PEDIATRIC DRUGS, 2017, 19 (05) : 463 - 478
  • [6] The Management of the Pediatric Neurogenic Bladder
    Sturm R.M.
    Cheng E.Y.
    Current Bladder Dysfunction Reports, 2016, 11 (3) : 225 - 233
  • [7] Pharmacotherapy for Pediatric Neurogenic Bladder
    Paweł Kroll
    Pediatric Drugs, 2017, 19 : 463 - 478
  • [8] Management of pediatric neurogenic bladder
    MacLellan, Dawn L.
    CURRENT OPINION IN UROLOGY, 2009, 19 (04) : 407 - 411
  • [9] BLADDER AUTOAUGMENTATION BY VESICOMYOTOMY IN THE PEDIATRIC NEUROGENIC BLADDER
    STOTHERS, L
    JOHNSON, H
    ARNOLD, W
    COLEMAN, G
    TEARLE, H
    UROLOGY, 1994, 44 (01) : 110 - 113
  • [10] Intravesical oxybutynin in the pediatric neurogenic bladder
    John Lazarus
    Nature Reviews Urology, 2009, 6 : 671 - 674